Science's $400M Neurotech Round Tops Week of Major Funding Announcements
A brain-computer interface startup led this week's funding activity, with eight other U.S. companies securing nine-figure rounds as market momentum persists despite recent tech stock volatility.

The past seven days saw robust venture activity across the U.S. startup ecosystem, with Science, a developer of brain-computer interface and neural engineering technology, capturing the top spot by raising $400 million in Series D funding. The Alameda, California-based company has now accumulated more than $900 million in total funding to date.
Beyond the neurotech leader, seven additional American startups announced venture or growth rounds exceeding $100 million. Internationally, London-based Isomorphic Labs, which focuses on applying artificial intelligence to drug discovery, secured $5 billion in Series C funding—the largest single financing of the week. Greenoaks and Sequoia Capital led that round for the five-year-old firm, which maintains offices in Massachusetts and Switzerland as well.
The week's activity reflects continued investor appetite despite recent headwinds. Anthropic's initial public offering dominated tech startup exits, though broader market pressures have weighed on technology equities in recent trading sessions. Should negative sentiment intensify, private market funding could face similar pressure.
Top 10 U.S. Funding Rounds
- Science, $400M Series D (neurotech): The Alameda, California-based brain-computer interface developer brings total funding to more than $900 million.
- Model ML, $250M Series B (AI and fintech): The New York and London-based platform serving financial and professional services closed at a $1.5 billion valuation, with General Atlantic and QED Investors leading.
- Galvanize Therapeutics, $130M Series D (biotech): The Redwood City, California developer of pulsed electric field ablation technologies for oncology and chronic disease was led by HealthQuest Capital.
- General Flash, $128M (critical metals): The developer of a novel method for producing critical metals raised across seed and Series A rounds.
- Ramon.Space, $124M Series B (space tech): The Denver-based space computing infrastructure company was led by PSG.
- Marrow Therapeutics, $120M Series B (biotech): The Watertown, Massachusetts developer of bone marrow-targeted therapies launched with combined Series A and B funding of $173 million, with Orbimed leading the Series B and Scion Life Sciences and venBio leading the $53 million Series A.
- Noeri, $110M initial funding (enterprise AI): The Palo Alto-based developer of self-improving AI for enterprises and researchers was founded by Stanford University computer science professors and was led by Menlo Ventures.
- Seawolf Therapeutics, $100M (biotech): The San Diego-based developer of a novel DNA delivery platform emerged from stealth with funding led by Versant Ventures, MPM BioImpact and Novartis Venture Fund.
- BrightAI, $97M (physical AI): The Silicon Valley-based developer of a sensor, drone and robotics-driven platform for infrastructure-heavy industries including power, water, and energy was led by Smith Point Capital.
- Vincue, $93M growth capital (vehicle intelligence): The Kansas City-based developer of a vehicle lifecycle intelligence platform was led by Wavecrest Growth Partners.
International Standout
- Isomorphic Labs, $5B Series C (AI and biotech): London-based startup applying AI to drug discovery, with offices in Massachusetts and Switzerland, was led by Greenoaks and Sequoia Capital.
Methodology
This analysis tracked the largest announced rounds in the Crunchbase database raised by U.S.-based companies during November 14–20, 2026. While most announced rounds appear in the database, some reporting delays may occur as certain rounds are disclosed later in the week.


